Better Buy: Kimberly-Clark Corp. vs. Johnson & Johnson
There aren't many companies that can grow sales and profits through a wide range of market conditions. But both Kimberly-Clark (NYSE: KMB), the consumer goods specialist, and Johnson & Johnson (NYSE: JNJ), the healthcare titan, have earned their place in that exclusive club. The 100 years of consecutive dividend raises that they boast between them is a testament to the enduring strength of their businesses.
Below, we'll stack these two income favorites against each other as investment ideas.
Kimberly-Clark
Source: Fool.com
Johnson & Johnson Stock
€149.88
-0.130%
The stock is one of the favorites of our community with 39 Buy predictions and 1 Sell predictions.
With a target price of 179 € there is a slightly positive potential of 19.43% for Johnson & Johnson compared to the current price of 149.88 €.
